J. Zugazagoitia

823 total citations · 1 hit paper
6 papers, 527 citations indexed

About

J. Zugazagoitia is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Molecular Biology. According to data from OpenAlex, J. Zugazagoitia has authored 6 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in J. Zugazagoitia's work include Lung Cancer Treatments and Mutations (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). J. Zugazagoitia is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). J. Zugazagoitia collaborates with scholars based in United States, Spain and China. J. Zugazagoitia's co-authors include Byoung Chul Cho, Christine M. Lovly, David Westover, Luis Paz‐Ares, Yi‐Long Wu, Guo‐Qiang Lin, Yi Zhao, Ute von Wangenheim, Maren Rohrbacher and M-J. Ahn and has published in prestigious journals such as Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

J. Zugazagoitia

3 papers receiving 521 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors

2018 518 citations David Westover, J. Zugazagoitia et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Zugazagoitia United States	3	375	291	225	130	44	6	527
Shigenari Nukaga Japan	9	398 1.1×	319 1.1×	224 1.0×	84 0.6×	35 0.8×	21	501
Chee-Seng Tan Singapore	3	326 0.9×	257 0.9×	286 1.3×	116 0.9×	35 0.8×	4	522
Shuhang Wang China	5	375 1.0×	328 1.1×	253 1.1×	112 0.9×	46 1.0×	8	539
Keita Masuzawa Japan	10	285 0.8×	239 0.8×	190 0.8×	67 0.5×	35 0.8×	24	418
Masaru Jida Japan	7	271 0.7×	251 0.9×	272 1.2×	105 0.8×	34 0.8×	14	469
Qinfang Deng China	13	302 0.8×	286 1.0×	229 1.0×	213 1.6×	30 0.7×	27	592
Annamaria Siggillino Italy	13	324 0.9×	256 0.9×	274 1.2×	138 1.1×	53 1.2×	24	514
Bin-Chi Liao Taiwan	15	561 1.5×	553 1.9×	217 1.0×	118 0.9×	39 0.9×	36	791
Lucía Regales United States	6	306 0.8×	286 1.0×	247 1.1×	69 0.5×	29 0.7×	10	457
Nele Van Der Steen Belgium	12	202 0.5×	187 0.6×	388 1.7×	147 1.1×	41 0.9×	21	560

Countries citing papers authored by J. Zugazagoitia

Since Specialization

Citations

This map shows the geographic impact of J. Zugazagoitia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Zugazagoitia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Zugazagoitia more than expected).

Fields of papers citing papers by J. Zugazagoitia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Zugazagoitia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Zugazagoitia. The network helps show where J. Zugazagoitia may publish in the future.

Co-authorship network of co-authors of J. Zugazagoitia

This figure shows the co-authorship network connecting the top 25 collaborators of J. Zugazagoitia. A scholar is included among the top collaborators of J. Zugazagoitia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Zugazagoitia. J. Zugazagoitia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Alexander, Marliese, Richy Agajanian, J. Zugazagoitia, et al.. (2025). 98P: Exploratory analysis showed increased overall survival among non-small cell lung cancer (NSCLC) patients with mutated KRAS compared with wildtype KRAS in a phase II trial of mecbotamab vedotin (CAB-AXL-ADC). Journal of Thoracic Oncology. 20(3). S72–S72.

2.

Soo, Ross A., E. Nadal, Yi‐Long Wu, et al.. (2025). PT2.12.03 Zongertinib in Patients With Previously Treated HER2-Mutant NSCLC and Brain Metastases at Baseline: Beamion LUNG-1. Journal of Thoracic Oncology. 20(10). S613–S614.

3.

Yamamoto, Norio, Yi‐Long Wu, Hai‐Yan Tu, et al.. (2025). LBA74 Zongertinib as first-line treatment in patients with advanced HER2-mutant NSCLC: Beamion LUNG 1. Annals of Oncology. 36. S1616–S1616.

4.

Yamamoto, Noboru, Hai‐Yan Tu, M-J. Ahn, et al.. (2024). LBA5 Zongertinib in patients with HER2-mutant NSCLC: Updated analysis of beamion LUNG-1. Annals of Oncology. 35. S1623–S1624. 3 indexed citations

5.

Ahn, M-J., Kiyotaka Yoh, J. Zugazagoitia, et al.. (2024). PL04.04 Primary Phase Ib Analysis of Beamion LUNG-1: Zongertinib (BI 1810631) in Patients with HER2 Mutation-Positive NSCLC. Journal of Thoracic Oncology. 19(10). S4–S5. 6 indexed citations

6.

Westover, David, J. Zugazagoitia, Byoung Chul Cho, Christine M. Lovly, & Luis Paz‐Ares. (2018). Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors. Annals of Oncology. 29(suppl_1). i10–i19. 518 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact